PRF1 and neoplasm: In contrast to the augmented tumor susceptibility to lysis upon azanucleoside-treatment, it has been reported that azacytidine induced expression of inhibitory KIRs and led to impaired granzyme B and perforin release resulting in limited cytolytic function (Gao et al., 2009).